-
3-Benzyl-3-azaspiro[bicyclo[3.2.1]octane-8,2'-[1,3]dioxolane]
-
BD4350621019208-04-898%
-
¥166.01g
-
8-Azaspiro[bicyclo[3.2.1]octane-3,2'-[1,3]dioxolane]
-
BD31485013375-57-095%
-
¥3165.01g
-
(1'R,3a'R,4a'R,8a'R,9'S,9a'S)-1'-Methyl-3'-oxo-N,N-diphenyldecahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carboxamide
-
BD682336900160-99-897%
-
¥
-
(1'R,3a'R,4a'R,8a'R,9'S,9a'R)-1'-Methyl-3'-oxodecahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carboxylic acid
-
BD234260226916-27-495+%
-
¥
-
1,4-Dioxa-7-azaspiro[4.5]dec-9-ene
-
BD28125284794-18-395+%
-
¥6020.01g
-
(3AS,4S,5S,6aR)-4-(2-(2-heptyl-1,3-dioxolan-2-yl)ethyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
-
BD638331120396-31-897%
-
¥
-
2-Oxo-4-(2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)vinyl)hexahydro-2H-cyclopenta[b]furan-5-yl [1,1'-biphenyl]-4-carboxylate
-
BD234908118392-79-395% mix TBC as stabilizer
-
¥6720.01g
-
(3a'S,7a'R)-1'-Benzyloctahydrospiro[[1,3]dioxolane-2,5'-indole]
-
BD1634321260608-58-995+%
-
¥
-
(S)-Dihydro-1'H-spiro[[1,3]dioxolane-2,6'-pyrrolo[1,2-c]oxazol]-3'(5'H)-one
-
BD4397291447616-10-597%
-
¥4459.01g
-
6-Oxaspiro[bicyclo[3.1.0]hexane-3,2'-[1,3]dioxolane]
-
BD62775540025-75-095%
-
¥966.0100mg
-
(3AR,4R,5R,6aS)-4-(2-(2-heptyl-1,3-dioxolan-2-yl)ethyl)-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-one
-
BD638332118696-65-497%
-
¥
-
(1'R,3a'R,8a'S,9'S,9a'S)-1'-Methyl-3'-oxo-N,N-diphenyl-3',3a',5',7',8',8a',9',9a'-octahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carboxamide
-
BD682335900160-98-797%
-
¥1286.0250mg
-
(4a'S,8a'R)-1'-Benzyloctahydro-1'H-spiro[[1,3]dioxolane-2,6'-quinoline]
-
BD1634421260605-48-895+%
-
¥
-
(S)-Tetrahydrospiro[[1,3]dioxolane-2,6'-pyrrolo[1,2-c]imidazol]-3'(5'H)-one
-
BD4397361447616-04-797%
-
¥6251.01g
-
Octahydrospiro[cyclopenta[c]pyridine-6,2'-[1,3]dioxolane]
-
BD4426651824432-28-197%
-
¥4291.01g
-
8-(1,3-Dioxolan-2-yl)hexahydroindolizin-5(1H)-one
-
BD66682288001-35-897%
-
¥